CONTACTS
SUBJECTS
VA Prescribe Atorvastin 10 MG Trial 4 Weeks Evaluate Side Effects In
6003 -
6003 - ..
6004 - Summary/Objective
6005 -
600501 - Follow up ref SDS 53 0000. ref SDS 51 0000.
600502 -
600503 -
600504 -
600506 - ..
6006 -
6007 -
6008 - Background
6009 -
6010 -
601001 - Lab on 131015, showing cholesterol remained high, 131015 0724,
601002 - ref SDS 36 BE6O, conflict with increased exercise and weight loss,
601003 - discussed in the letter to the medical team yesterday on 131016 1632.
601004 - ref SDS 37 IW57
601006 - ..
601007 - On 131017 1000 VA medical chart Progress Notes assessment report
601008 - patient status CAD stable, asymptomatic. hyperlipidemia not
601009 - controlled. ref SDS 38 T24N
601011 - ..
601012 - On 131017 1000 Doctor Egan proposed referring patient for clinical
601013 - trial to reduce cholesterol with new "targeted" drugs. ref SDS 38 179N
601015 - ..
601016 - On 131017 1000 VA medical chart Progress Notes assessment report
601017 - patient status hyperlipidemia not controlled, ref SDS 38 PSXT; Doctor
601018 - Egan makes referral to SF VA Medical Center for consult on
601019 - participation clinical trials, ref SDS 38 EU9F, with experimental
601020 - agents such as AMG 145 and REGN 727 to resolve multiple statin
601021 - intolerances. ref SDS 38 CN4H
601023 - ..
601024 - On 131103 received letter from VA SF Medical Center scheduling meeting
601025 - on 131121 1000, to consider clinical trial for lowering cholesteral.
601026 - ref SDS 39 YT4N
601028 - ..
601029 - On 131112 New York Times published several articles reporting that the
601030 - day before on 131113, American Heart Association published new
601031 - guidelines for treating CAD patients that expand use of statin
601032 - medication regardless of cholesterol levels, ref SDS 40 0001, and
601033 - further raise the LDL 70 to LDL 190, as a target for cardiovascular
601034 - risk. ref SDS 40 CW6H
601036 - ..
601037 - On 131114 New York Times published several articles reporting that the
601038 - day before on 131113, American Heart Association published new
601039 - guidelines for treating CAD patients. ref SDS 41 SH6G
601041 - ..
601042 - On 131121 1604 meeting with Doctor Alba at San Francisco Medical
601043 - Center - prescribed Atorvastatin 20 mg 4-week trial and evaluate
601044 - adding Zetia 10 mg, schedule follow up on 131219 0930. ref SDS 42 6H6K
601046 - ..
601047 - On 131121 1604 in another record later today, VA prescription RX #
601048 - 5674471 for Atorvastatin 20 mg has been ordered. ref SDS 43 GH5M
601050 - ..
601051 - On 131125 0005 letter from Karen reports VA work plan to take statin
601052 - drug low dose Atvorstatin 10 mg for 4 weeks, then add Zetia 10 mg in
601053 - clinical trial for lowering cholesterol. ref SDS 45 V154
601055 - ..
601056 - On 131125 0005 research seems to indicate this clincial trial of low
601057 - dose Atorvasatatin 10 mg with Zeitia 10 mg has lowered cholesterol LDL
601058 - 70.
601060 - ..
601061 - On 131205 1448 received new prescription for Atvorstatin 20 mg,
601062 - ordered by Doctor Alba today for 4-week trial to assess side effects
601063 - for adding 2nd drug, Zetia 10 mg to lower LDL 249. ref SDS 46 GH5M
601065 - ..
601066 - On 131216 0028 letter to Doctor Alba submit agenda for meeting at VA
601067 - SFMC on 131219. ref SDS 47 HY6O
601069 - ..
601070 - On 131219 0930 meeting Doctor Alba at San Francisco VA Medical Center
601071 - ordered Ezedimibe 10 mg prescription for adding to Atorvastatin, and
601072 - ordered blood test to evaluate changes in lipid profile. 131219 0930,
601073 - ref SDS 48 NJ6G
601075 - ..
601076 - On 131230 1450, received Ezetimibe in US mail, ref SDS 49 5N3O,
601077 - ordered by Doctor Alba on 131219, 131219 0930, ref SDS 48 6H6K; begin
601078 - trial to manage cholesterol with Atorvastatin 10 mg and Ezetimibe 10
601079 - mg, planned during meeting at VA on 131121 0930. ref SDS 42 6H6K
601081 - ..
601082 - On 140114 0845 letter to Diana request Progress Notes meeting 131219,
601083 - ref SDS 50 HY6O, and ask about expanding scope pending lab to include
601084 - LDL-P. ref SDS 50 2140
601086 - ..
601087 - On 140115 1842 letter Diana will look for Progress Notes meeting
601088 - 131219, ref SDS 52 HY6O; investigating prospects for ordering lab test
601089 - LDL-P, ref SDS 52 CE80; VA claims patient cholesterol and LDL are above
601090 - target. ref SDS 52 CE91 VA further claims testing LDL-P not effective
601091 - in this case because LDL-C is not optimal. ref SDS 52 FF4H
601093 - ..
601094 - On 140116 0814 letter thanks Doctor Alba for investigting to find
601095 - Progress Notes for meeting at VA on 131219. ref SDS 53 HY6O Cite
601096 - research indicating patient with discordant LDL-C high and LDL-P low,
601097 - shown in patient lab on 131015, constitutes least risk for
601098 - arterialsclorosis disorder, CVD, mycardial infarction. ref SDS 53 735Y
601100 - ..
601101 - On 140128 1327 letter asks again about Progress Notes meeting 131219,
601102 - ref SDS 0 HY6O; report hiking 11 miles per day continued, weight hit
601103 - 165, ref SDS 0 TZ8U; ask where to get lab at VA Martinez, in San
601104 - Francisco, or at UCSF. ref SDS 0 TZ96 No side effects from
601105 - Atorvastatin and Ezetimibe. ref SDS 0 TZ99
601106 -
601107 -
601108 -
601110 - ..
6012 -
6013 -
6014 - Progress
6015 -
601501 - Progress Notes Submit for Meeting at VA SFMC 131219
601502 - Hyperlipidemia Control Exercise Diet Medication Atorvastatin Ezetimibe
601503 -
601504 - Follow up ref SDS 53 HY6O, ref SDS 51 HY6O.
601505 -
601506 - Letter to Diana Alba, MD says...
601507 -
601508 -
601509 - 1. Subject: Pending Lab Include LDL-P Evaluate Discordance
601510 - Date: 2014-01-28 13:56
601514 - ..
601515 - 2. Dear Doctor Alba,
601517 - ..
601518 - 3. Patient......... 0144
601520 - ..
601521 - 4. Following up the letter on 140116, ref SDS 53 HY6O - have you
601522 - had a chance to locate Progress Notes for the meeting on
601523 - 131219, planned in your letter on 140115? Please submit a
601524 - copy.
601525 -
601526 -
601528 - ..
601529 - LDL-P Add to Pending Lab Evaluate Discordant
601530 - Hyperlipidemia Patient Discordant Test Pending Lab LDL-P
601531 -
601532 - Follow up ref SDS 53 CE80, ref SDS 51 CE80.
601533 -
601534 - Letter to Doctor Alba's continues...
601536 - ..
601537 - 5. Good news - fair weather enables continued exercise toward
601538 - weight loss. As planned in the meeting on 131219, finally hit
601539 - 165 last week on 140121 (see case study dated 120101, line
601540 - 101240. ref SDS 12 A39H
601542 - ..
601543 - 6. You can see in the study that weight bounced back, but hoping
601544 - to stabilize at 165 over the next few weeks, then tackle 160,
601545 - based on lab results.
601547 - ..
601548 - 7. You were looking for more research on discordance to test
601549 - LDL-P. [...reported in Doctor Alba's letter on 140115 1842.
601550 - ref SDS 51 PH5I...]. Any luck?
601552 - ..
601553 - 8. Should hit 165 again this week or next, and will then get the
601554 - lab. Please let me know if I should come to SFMC or UCSF for
601555 - the blood draw. Should we do it locally in Martinez? [...
601556 - following up letter to VA on 140116 0814. ref SDS 53 H253...]
601557 -
601558 - [On 140131 0815 have not received instructions from VA on
601559 - getting lab to test LDL-P, so ordered test. ref SDS 54 OO5G
601560 - lab blood draw at Labcorp in Walnut Creek on Ygnacio Valley
601561 - Road. ref SDS 54 NT6T
601563 - ..
601564 - [On 140201 1159 obtained blood draw for testing LDL-P at
601565 - Labcor on Health Testing Centers order # 27716. ref SDS 55
601566 - KQ4L
601568 - ..
601569 - [On 140203 1147 obtained blood draw at VA to cross check
601570 - Labcorp blood test. 140203 1147, ref SDS 56 KK9M
601572 - ..
601573 - [On 140204 1236 letter from VA says to get blood draw for
601574 - lab at VA San Francisco Medical Center (SFMC), ref SDS 57
601575 - PT3M, responding to inquiry in letter to VA on 140128.
601576 - ref SDS 0 TZ96
601578 - ..
601579 - 9. There have been no evident side effects of atorvastatin 10 mg
601580 - and ezetimibe 10 mg. There is a slight rash above left eye.
601581 - You can see from patient history treatment for rosacia by
601582 - Doctor Margulies beginning on 070221. ref SDS 1 BM62
601584 - ..
601585 - 10. There is also some rash below the knees on both legs, but this
601586 - may be sun exposure during hiking.
601588 - ..
601589 - 11. Assuming these are not related to atorvastatin and ezetimibe,
601590 - there are no side effects from the current treatment.
601592 - ..
601593 - 12. Otherwise, seem healthy. Vitals are good. Shoulders have
601594 - recovered enough from taking Rosuvastatin to enable doing
601595 - pushups again. Very fortunate.
601597 - ..
601598 - 13. Looking forward to meeting on 140213.
601599 -
601605 -
601606 -
601607 -
601608 -
601609 -
601610 -
601611 -
601612 -
601613 -
601614 -
601615 -
601616 -
601617 -
6017 -